Conducting cancer trials amid the COVID-19 pandemicApril 8, 2020COVID-19 UpdatesMelanomaLung CancerGenitourinary CancerBreast Cancer
NCCN panel: Defer nonurgent skin cancer care during pandemicApril 7, 2020COVID-19 UpdatesMelanomaOncology
‘Brutal’ plan to restrict palliative radiation during pandemicApril 6, 2020COVID-19 UpdatesBreast CancerGenitourinary CancerLung CancerMelanomaOncology
Advice from the front lines: How cancer centers can cope with COVID-19April 2, 2020COVID-19 UpdatesBreast CancerGenitourinary CancerLung CancerMelanomaOncology
No staff COVID-19 diagnoses after plan at Chinese cancer centerApril 2, 2020COVID-19 UpdatesBreast CancerGenitourinary CancerLung CancerMelanomaOncology
Maintaining cancer care in the face of COVID-19April 1, 2020COVID-19 UpdatesGenitourinary CancerLung CancerMultiple MyelomaMelanomaInfectious DiseasesOncology
Cancer care and COVID-19 in Seattle, the first U.S. epicenterMarch 23, 2020COVID-19 UpdatesBreast CancerGenitourinary CancerLung CancerMelanomaOncology
How is oncology adapting to COVID-19?March 23, 2020COVID-19 UpdatesBreast CancerGenitourinary CancerLung CancerMelanoma
Disruptions in cancer care in the era of COVID-19March 20, 2020COVID-19 UpdatesBreast CancerGenitourinary CancerLung CancerMelanomaOncology
Lenvatinib/pembrolizumab has good activity in advanced RCC, other solid tumorsJanuary 31, 2020Immuno-oncologyGenitourinary CancerMelanomaLung CancerOncology
Sharp declines for lung cancer, melanoma deaths fuel record drop in cancer mortalityJanuary 16, 2020Lung CancerMelanomaOncology
Combo elicits lasting responses in metastatic melanomaNovember 25, 2019MelanomaImmuno-oncologyOncologyDermatology
